Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ: VRTX · Real-Time Price · USD
427.89
+5.89 (1.40%)
Jan 21, 2025, 4:00 PM EST - Market closed
Vertex Pharmaceuticals Analyst Ratings
Total Analysts
30
Consensus Rating
Buy
Price Target
$503.92
Upside
+17.77%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $555 → $460 | Buy | Maintains | $555 → $460 | +7.50% | Jan 10, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $550 → $460 | Strong Buy | Maintains | $550 → $460 | +7.50% | Dec 23, 2024 |
| Scotiabank | Scotiabank | Hold Maintains $426 → $430 | Hold | Maintains | $426 → $430 | +0.49% | Dec 23, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $503 → $500 | Buy | Maintains | $503 → $500 | +16.85% | Dec 23, 2024 |
| Barclays | Barclays | Hold Maintains $509 → $418 | Hold | Maintains | $509 → $418 | -2.31% | Dec 20, 2024 |
| BMO Capital | BMO Capital | Buy Maintains $566 → $520 | Buy | Maintains | $566 → $520 | +21.53% | Dec 20, 2024 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Dec 20, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $600 → $535 | Strong Buy | Maintains | $600 → $535 | +25.03% | Dec 20, 2024 |
| B of A Securities | B of A Securities | Strong Buy Maintains $545 → $522 | Strong Buy | Maintains | $545 → $522 | +21.99% | Dec 19, 2024 |
| Stifel | Stifel | Hold Maintains $490 → $494 | Hold | Maintains | $490 → $494 | +15.45% | Dec 16, 2024 |
| Jefferies | Jefferies | Hold → Strong Buy Upgrades $500 → $550 | Hold → Strong Buy | Upgrades | $500 → $550 | +28.54% | Dec 9, 2024 |
| Citigroup | Citigroup | Strong Buy Initiates $575 | Strong Buy | Initiates | $575 | +34.38% | Nov 14, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Sell Maintains $361 → $408 | Strong Sell | Maintains | $361 → $408 | -4.65% | Nov 6, 2024 |
| Scotiabank | Scotiabank | Hold Maintains $480 → $486 | Hold | Maintains | $480 → $486 | +13.58% | Nov 5, 2024 |
| UBS | UBS | Strong Buy Maintains $562 → $586 | Strong Buy | Maintains | $562 → $586 | +36.95% | Nov 5, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $480 | Buy | Reiterates | $480 | +12.18% | Nov 5, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.